Artisan Global Value team to split from International Value team.
Like going public, this appears to be about getting people paid.

https://m.nasdaq.com/article/the-best-bonds-for-rising-rates-cm1020114
FINSUM, September 10, 2018, 10:05:23 AM EDT
(New York)
This is a tough time to be buying bonds. Prices have become very rich over the last several years and on top of sky high valuations and low yields the risk of rising rates causing big losses is high as the Fed sticks to its hawkish path. With that in mind, floating rate bonds and ETFs are a good strategy to combat the situation,

FYI: U.S. stocks mostly rose Monday, with the S&P 500 and the Nasdaq snapped their four-day losing streak on the back of a recovery in technology shares.
The Dow Jones Industrial Average slipped 57 points, however, as Apple lost more than 1 percent. Transports, meanwhile, rallied 1.9 percent to an all-time high.
The benchmark S&P 500 and the Nasdaq edged higher lead by industrial stocks, on optimism for further tax relief, although a drop in Apple kept gains in check
Republicans in the U.S. House of Representatives plan to unveil tax cuts this week, intended to augment President Donald Trump’s 2017 tax overhaul that added $1.5 trillion to the federal deficit through permanent tax cuts for U.S. companies.
The day’s gains were fairly broad-based, with nine of the 11 primary S&P 500 industry groups in positive territory led by utilities and real estate. Financials and healthcare had a down day.
Regards,
Ted
Bloomberg:
https://www.bloomberg.com/news/articles/2018-09-09/asia-stocks-point-to-drop-dollar-holds-advance-markets-wrap
Bloomberg Evening Briefing:
https://www.bloomberg.com/news/articles/2018-09-10/your-evening-briefing
Barron's After The Bell:
https://www.barrons.com/articles/dow-loses-59-points-as-trade-talk-takes-a-toll-1536614237
WSJ:
https://www.wsj.com/articles/trade-barbs-pressure-global-stocks-1536566752
Reuters:
https://www.reuters.com/article/us-usa-stocks/wall-street-rises-on-tax-optimism-despite-apple-drag-idUSKCN1LQ1I8
IBD:
https://www.investors.com/market-trend/stock-market-today/apple-sinks-on-trade-war-fear-will-this-sector-help-dow-beat-the-nasdaq-in-q3/
MarketWatch:
https://www.marketwatch.com/story/us-stocks-set-to-bounce-higher-after-last-weeks-drop-2018-09-10/print
CNBC:
https://www.cnbc.com/2018/09/10/us-markets-us-china-trade-frictions-in-focus.html
Europe:
https://www.cnbc.com/2018/09/10/european-markets-trade-concerns-take-center-stage.html
Asia:
https://www.reuters.com/article/japan-stocks-close/nikkei-snaps-6-day-losing-streak-on-upbeat-japan-gdp-trade-worries-remain-idUSL3N1VW33R
Bonds:
https://www.cnbc.com/2018/09/10/us-bonds-and-fixed-income-us-china-trade-dispute-in-focus.html
Currencies:
https://www.cnbc.com/2018/09/10/forex-markets-us-dollar-china-us-trade-in-focus.html
Oil:
https://www.cnbc.com/2018/09/10/oil-markets-us-energy-us-sanctions-on-iran-china-us-trade-in-focus.html
Gold
https://www.cnbc.com/2018/09/10/gold-fed-interest-rate-policy-us-china-trade-tensions-in-focus.html
WSJ: Markets At A Glance:
http://markets.wsj.com/us
Major ETFs % Change:
https://www.barchart.com/etfs-funds/etf-monitor
SPDR's Sector Tracker:
http://www.sectorspdr.com/sectorspdr/tools/sector-tracker
SPDR's Bloomberg Sector Performance Pie Chart:
https://www.bloomberg.com/markets/sectors
Current Futures: Positive
https://finviz.com/futures.ashx

All types of Monte Carlo simulators are currently available on the Internet. I never explored life expectancy ones before your question, but they too exist. Here is one from Vanguard:
https://personal.vanguard.com/us/insights/retirement/plan-for-a-long-retirement-tool
I have no idea how good or reliable it is, but it is probably a respectable starting point. Good luck and a long life expectancy.

Better yet, have a long life and beat the odds!
The Vanguard page doesn't do simulations. It basically just does table lookups: "Calculations are based on mortality data from the Society of Actuaries Retirement Participant 2000 Table."
https://www.soa.org/experience-studies/2000-2004/research-rp-2000-mortality-tables/
It calculates the probability of at least one surviving as:
100% - (probability of person A dying) x (probability of person B dying)
This calculation has the same flaw that many investment Monte Carlo simulations have. They assume that events are independent: there are no economic cycles; the death of one spouse has no effect on the life expectancy of the survivor.
The Science of Longtime Couples Who Die Close Together
https://www.thecut.com/2015/11/science-of-longtime-couples-who-die-together.html

"The 4% retirement rule ... is based on multiple studies that included using Monte Carlo analyses"
What the WSJ article says: "Based on pioneering research in the early 1990s by William Bengen, then a financial planner in California, the so-called 4% rule states that retirees can pull about 4% annually from their nest egg (a figure Mr. Bengen eventually set at 4.5%), with a high probability that their savings will last 30 years."
Bengen's research had nothing to do with Monte Carlo analyses, such as "This Vanguard Monte Carlo calculator."
Bengen said so himself: "Let me add that I am a great admirer of Vanguard and their effort to serve investors well with low-cost, well-managed funds. I use their funds in my personal portfolio. But our approach to computing "safe" withdrawal rates ... is quite different."
https://www.aaii.com/journal/article/insights-on-using-the-withdrawal-rule-from-its-creator
That excellent 2018 interview with Bengen was linked to by the WSJ article. To me what is interesting is not so much the 4% figure as why he picked a thirty year target. (FWIW, in 1994, the IRS joint life table for a couple of 65 year olds was 25 years. The current Table III shows 27.4 years for a 70 year old couple, so we can assume that a 65 year old couple would have at least a 30 year life expectancy per IRS today).
Also, in his followup that I quoted from above, he addressed @slick's 3.5%

In contrast, my methods use actual historical returns and inflation rates in the order in which they occurred. Vanguard's methods create sequences of returns and inflation which probably never happened in reality. As a result, they may generate "worst case" scenarios worse than anything that has ever happened, while my methods search for the worst case that has actually occurred.
Note also that Vanguard uses different asset classes than I do in my research.

When you change things like that, numbers can change radically.

No. The EM has worsen with increased political risk in the last several months. Another headwinds it faces are trade wars, strong USD, and two rate hikes in 2018.

@slick,
Here is copy from Stocktrader's Weekly Market Recap (09/09/18) on emerging markets. It reads ...
"Keep an eye on emerging markets – we’ve seen rustling out of Turkey, Argentina, South Africa, etc – it’s still pretty quiet out there but in 1997 a market dislocation hit due to an event in Thailand of all places so the general weakness we are seeing in many emerging markets won’t matter – until it does."
and
"A team led by Marko Kolanovic, global head of macro quantitative and derivatives strategy at J.P. Morgan, blamed the weakness in global markets to a “risk-off” mode with investors seeking to minimize their exposure to risky assets such as stocks amid concerns about contagion from emerging markets as well as the impact of the stronger U.S. dollar and higher interest rates."
Again, with this, I plan no near term action to increase my allocation to emerging markets. I've got some funds within my portfolio that roam the investment universe and position accordingly so if I miss a strategy move into emerging markets myself they most likely will key upon it.
For me to move ... I'll need to see a weaness in the US Dollar along with a tappering in the FOMC rate increase campaign.

FYI: Some experts argue for withdrawal strategies tied to changing conditions.
Regards,
Ted
https://www.wsj.com/articles/the-4-retirement-rule-is-just-a-starting-point-1536245877?mod=article_inline

this is smart
https://www.washingtonpost.com/opinions/the-dangerous-myth-we-still-believe-about-the-lehman-brothers-bust/2018/09/09/5a2f8a9c-b2bc-11e8-9a6a-565d92a3585d_story.html

All ratings have been updated on MFO Premium site, including MultiSearch, Great Owls, Fund Alarm (Three Alarm and Honor Roll), Averages, Correlation, Dashboard of Profiled Funds, Fund Family Scorecard, Calendar Year Performance and Ferguson Metrics.
This month with added a Trend analysis option to MultiSearch Results page, which indicates when funds are above or below their 3- and 10-month simple moving averages. More on that in the upcoming commentary.

@slick et al
A one year chart for VWO reference.
One will see where the 50 and 100 day moving averages have traveled below the 200 day moving average; and still moving down.

"which is more than emerging markets right now "
Tell me. At least some of my cash is earning 2.5% on 14 month CDs. I try to ignore our EM equities.

@slick: I would stay away from the vast majority of emerging markets for the foreseeable future. Here is some info for your consideration regarding EM's.
Regards,
Ted
http://www.investmentnews.com/article/20180713/FREE/180719955/emerging-markets-have-yet-to-reach-bottom

Back i January 2018 I jumped into an additional emerging market fund GQGPX (already had SIGIX) whose manager Rajiv Jain I had experience with when he was with Vontobel (had the fund for 4 years) but he left to from his own boutique firm. I had bought a fund he subadvised at Goldman Sachs in September 2017 GSIHX since his emerging stock fund was not available at Fidelity, but found it available at TD America so I jumped in January 2018 awaiting its availability on the Fidelity platform at some point. Made a nice return until emerging markets tanked, and sold GQGPX in July 2018. Since it was in a taxable account, decided to sell since I had some substantial profits in a stock I sold in January (ABBV).
Emerging markets have declined substantially since I sold GQGPX, and I am wondering if its near a bottom, it is now available at Fido, and can put into into my Roth. I have been adding to its sister fund GSIHX, but have enough in there now. It is mostly in developed market. Holding onto SIGIX despite its recent history, as I buy good managers, and tend give them at least 2 years to come back when they falter, especially if their part of the market is more the issue, but have reduced it a bit in favor of Jain's fund.
Anyone else think emerging markets are ready to buy? All opinions welcome :)

Thanks for the reply. Yet, I'm needing all the yield I can get. 14.2% of RPIHX is "other." WTF? Convertibles? Shorts? I'm planning to put big chunks into TRP domestic junk. TUHYX. Nothing in it yet. Other current bond holdings are PRSNX and PTIAX.

Good find!
I live practically across from the Pentagon - but I felt more existential dread during Sep-Oct '08 than I did on 9/11 even as smoke blew across my balcony for 4 days afterward.
On Fridays during '08 you felt a relief as the markets closed, knowing you had at least a day before the next likely spot of bad news would come out Sunday night before Asia opened.
I remember trading futures the day they took the first TARP vote in the House -- the one that failed and tanked the Dow 1000 points that hour. Forget CNBC, the markets were locked onto CSPAN and the vote count.
The only good (if not admittedly greedy & self-serving) thing about those days was that you could take much of the day off, and then come in, throw on some short futures positions around 2:30-3PM and let them ride water-flume style until the close, netting yourself a BIG profit on the day. You could do that pretty much like clockwork back then -- if you knew what you were doing, obviously! Heck, you didn't need to throw down an over-leveraged position if you didn't want to ... just 4 or 8 eminis would score you a VERY nice win on the day. (I think the most I ever traded were 16 eminis at one time ... I got a profit but it made me too uncomfortable, so I didn't do it again.)

FYI: While technology stocks tend to make the flashiest headlines, the health-care sector remains one of the most consistent outperformers.
The exchange traded funds have more than tripled the returns of the S&P 500 this year.
Regards,
Ted
https://www.fidelity.com/insights/investing-ideas/health-care-etfs-to-consider

Excellent article and research, Lewis. It made me look at Large Growth PROVX, one that has been mentioned here recently, and fits your criteria well.
From M* as of 9/7:
2008 Total Return -21.00
1YR Total Return 25.33
1 YR Category Return 26
10 YR Total Return 10.79
10 YR Category Return 64
5 YR Downside Capture Ratio (as of 8/31) 65.53

@Ted:
As I mentioned in another thread, thanks to you I'm ahead $61 so far.

Is that 61 Bil or 61 Mil? I suppose it becomes hard to count after a while. :)
Knew a guy once who invested a great deal of his and his wife's retirement monies in some big distillers - mainly so she couldn't complain when he "sampled" their products - which was often.

FYI: The financial crisis brought the global economy to the brink, with many regarding the bankruptcy of investment bank Lehman Brothers in September 2008 as the seminal moment of the great recession. That same year, the U.S. housing market went under water, J.P. Morgan acquired Bear Stearns in record time as it too faced collapse, stock markets crashed and the Federal Reserve slashed interest rates to their lowest in history. Ten years on, the J.P. Morgan Research team explores what has changed and what the future could hold for the global economy and markets
Regards,
Ted
https://www.jpmorgan.com/global/research/10-years-after-crisis